Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 26, 2021
COVID-19 chemoprevention
Cintia Cruz, Nicholas J White
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 17, 2026
Pediatric Chagas disease
Facundo Garcia-Bournissen, Cintia Cruz, Jaime Altcheh
British Journal of Clinical Pharmacology
|
July 1, 2026
Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study
Kouki Tomari, Ruud H J Verstegen, Cintia Cruz, et al.
Plos Neglected Tropical Diseases
|
September 22, 2025
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)
Frauke Assmus, Cintia Cruz, James A Watson, et al.
The Lancet. Microbe
|
September 11, 2025
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
BMC Infectious Diseases
|
January 15, 2024
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Viravarn Luvira, William H K Schilling, Podjanee Jittamala, et al.
Elife
|
February 21, 2023
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Lancet. Infectious Diseases
|
October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Journal of Infectious Diseases
|
July 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Podjanee Jittamala, William H K Schilling, James A Watson, et al.
Eclinicalmedicine
|
February 3, 2025
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Podjanee Jittamala, Simon Boyd, William H K Schilling, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 26, 2021
COVID-19 chemoprevention
Cintia Cruz, Nicholas J White
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 17, 2026
Pediatric Chagas disease
Facundo Garcia-Bournissen, Cintia Cruz, Jaime Altcheh
British Journal of Clinical Pharmacology
|
July 1, 2026
Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study
Kouki Tomari, Ruud H J Verstegen, Cintia Cruz, et al.
Plos Neglected Tropical Diseases
|
September 22, 2025
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)
Frauke Assmus, Cintia Cruz, James A Watson, et al.
The Lancet. Microbe
|
September 11, 2025
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, et al.
BMC Infectious Diseases
|
January 15, 2024
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Viravarn Luvira, William H K Schilling, Podjanee Jittamala, et al.
Elife
|
February 21, 2023
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Lancet. Infectious Diseases
|
October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
William H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Journal of Infectious Diseases
|
July 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Podjanee Jittamala, William H K Schilling, James A Watson, et al.
Eclinicalmedicine
|
February 3, 2025
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Podjanee Jittamala, Simon Boyd, William H K Schilling, et al.
Page
of 1